Adenosine modulates oesophageal sensorimotor function in humans

Gut

Volumn 58, Issue 8, 2009, Pages 1049-1055

  Remes Troche, J M ^a   Chahal, P ^a   Mudipalli, R ^a   Rao, S S C ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; PLACEBO; WATER;

ADULT; ARTICLE; BIOMECHANICS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISCOMFORT; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG INFUSION; ESOPHAGUS; FEMALE; FLUSHING; HEADACHE; HUMAN; HYPERALGESIA; IMPEDANCE; MALE; MODULATION; NAUSEA; PATHOGENESIS; PERCEPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSORIMOTOR FUNCTION; SENSORY SYSTEM; SIDE EFFECT; SORE THROAT; THORAX PAIN; VISCERAL PAIN; VOLUNTEER;

ADENOSINE; ADULT; BIOMECHANICS; DOUBLE-BLIND METHOD; ELECTRIC IMPEDANCE; ESOPHAGUS; FEMALE; HEART RATE; HUMANS; HYPERALGESIA; MALE; MIDDLE AGED; PAIN MEASUREMENT; PAIN THRESHOLD; SENSORY THRESHOLDS; YOUNG ADULT;

EID: 67650245520     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2006.116699     Document Type: Article

References (62)

1. Richter JE, Barish CF, Castell DO. Abnormal sensory perception in patients with esophageal chest pain. Gastroenterology 1986;91:845-852.
2. Sarkar S, Aziz Q, Woolf CJ, et al. Contribution of central sensitization to the development of non-cardiac chest pain. Lancet 2000;356:1154-9.
3. Fass R, Dickman R. Non-cardiac chest pain: an update. Neurogastroenterol Motil 2006;18:408-17.
4. Chahal PS, Rao SSC. Functional chest pain: nociception and visceral hyperalgesia. J Clin Gastroenterol 2005;39:S204-9.
5. Rao S, Gregersen H, Hayek B, et al. Unexplained chest pain: the hypersensitive, hyperreactive, and poorly compliant esophagus. Ann Intern Med 1996;124:950-8.
6. Rao S, Hayek B, Summers R. Functional chest pain of esophageal origin: hyperalgesia or motor dysfunction. Am J Gastroenterol 2001;96:2584-9.
7. Aziz Q, Andersson J, Valind S, et al. Identification of human brain loci processing esophageal sensation using positron emission tomography. Gastroenterology 1997;113:50-9.
8. Hobson AR, Aziz Q. Brain processing of esophageal sensation in health and disease, Gastroenterol Clin North Am 2004;33:69-91.
9. Mehta AJ, De Caestecker JS, Camm AJ, et al. Sensitization to painful distention and abnormal sensory perception in the esophagus. Gastroenterology 1995;108:311-9.
10. Willert PR, Woolf CJ, Hobson AR, et al. The development and maintenance of human visceral pain hypersensitivity is dependent on the N-methyl-D-aspartate receptor. Gastroenterology 2004;126:683-92.
11. Beattie DT, Smith JA, Marquess D, et al. The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo. Br J Pharmacol 2004;143:549-60.
12. McRoberts JA, Coutinho SV, Marvizon JC, et al. Role of peripheral N-methyl-Daspartate (NMDA) receptors in visceral nociception in rats. Gastroenterology 2001;120:1737-48.
13. Bertrand C, Nadel JA, Yamawaki I, et al. Role of kinins in the vascular extravasation evoked by antigen and mediated by tachykinins in guinea pig trachea. J Immunol 1993;151:4902-7.
14. Sengupta JN, Saha JK, Goyal RK. Differential sensitivity of bradykinin to ED-sensitive mechanoreceptor in vagal and sympathetic afferents of the opossum. J Neurophysiol 1992;68:1053-67.
15. Page AJ, Blackshaw LA. An in vitro study of the properties of vagal afferent fibres innervating the ferret oesophagus and stomach. J Physiol 1998;512:907-16.
16. Page AJ, Blackshaw LA. GABA B receptors inhibit mechanosensitivity of primary afferent endings. J Neurosci 1999;19:8597-602.
17. Page AJ, Slattery JA, O'Donnell TA, et al. Modulation of gastro-oesophageal vagal afferents by galanin in mouse and ferret. J Physiol 2005;563:809-19.
18. Julia V, Su X, Bueno L, et al. Role of neurokinin 3 receptors on responses to colorectal distention in the rat: electrophysiological and behavioral studies. Gastroenterology 1999;116:1124-31.
19. Petrocellis DL, Chu CJ, Moriello AS, et al. Actions of two naturally occurring saturated N-acyldopamines on transient receptor potential vanilloid 1 (TRPV1) channels. Br J Pharmacol 2004;143:251-6.
20. Petrocellis DL, Di Marzo V. Lipids as regulators of the activity of transient receptor potential type V1 (TRPV1) channels. Life Sci 2005;77:651-66.
21. Ross RA. Anandamide and vanilloid TRPV1 receptors. Br J Pharmacol 2003;140:790-801.
22. Varaia I, Logue E, O' Connor C, et al. Randomized trial of sertraline in patients with unexplained chest pain of non cardiac origin. Am Heart J 2000;140:367-72.
23. Broekaert D, Fischler B, Sifrim D, et al. Influence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a double-blind, placebo-controlled study. Aliment Pharmacol Ther 2006;23:365-70.
24. Rodriguez-Stanley S, Zubaidi S, Proskin HM, et al. Effect of tegaserod on esophageal pain threshold, regurgitation and symptom relief in patients with functional heartburn and mechanical sensitivity. Clin Gastroenterol Hepatol 2006;4:442-50.
25. Peghini PL, Katz PO, Castell DO. Imipramine decreases oesophageal pain perception in human male volunteers. Gut 1998;42:807-13.
26. Prakash C, Clouse RE. Long term outcome of tricyclic antidepressant treatment of functional chest pain. Dig Dis Sci 1999;44:81-90.
27. Clouse RE, Lustman PJ, Eckert TC, et al. Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebocontrolled trial. Gastroenterology 1987;92:1027-36.
28. Rao S, Mudipalli R, Mujica V, et al. An open-label trial of theophylline for functional chest pain. Dig Dis Sci 2002;47:2763- 68.
29. Rao SSC, Mudipalli R, Remes-Troche JM, et al. Theophylline improves esophageal chest pain-a randomized placebo controlled study. Am J Gastroenterol 2007;102:930-8.
30. Sylven C, Beerman B, Jonzon B, et al. Angina pectoris like pain provoked by intravenous adenosine in healthy volunteers. BMJ 1986;293:227-30.
31. Minton NA, Henry JA. Pharmacodynamic interaction between infused adenosine and oral theophylline. Hum Exp Toxicol 1991;10:411-8.
32. Segerdahl M, Karelov A. Experimentally induced ischaemic pain in healthy humans is attenuated by the adenosine receptor antagonist theophylline. Acta Physiol Scand 2004;180:301-6.
33. Liu XJ, Salter MW. Purines and pain mechanisms: recent developments. Curr Opin Investig Drugs 2005;6:65-75.
34. Sawynok J. Adenosine receptor activation and nociception. Eur J Pharmacol 1998;347:1-11.
35. Jacobson KA, Gao ZG. Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 2006;5:247-64.
36. Bleehen T, Keele CA. Observation on the algogenic actions of adenosine compounds on the human blister base preparation. Pain 1997;3:367-77.
37. Sylven C, Jonzon B, Fredholm BB, et al. Adenosine injection into the brachial artery produces ischemia like pain or discomfort in the forearm. Cardiovasc Pharmacol 1988;16:962-5.
38. Gaspardone A, Crea F, Tomai F, et al. Muscular and cardiac adenosine-induced pain is mediated by A1 receptors. J Am Coll Cardiol 1995;25:251-7.
39. Pappagallo M, Gaspardone A, Tomai F, et al. Analgesic effect of bamiphylline on pain induced by intradermal injection of adenosine. Pain 1993;53:199-204.
40. Kollarik M, Ru F. Adenosine activates a subset of nociceptive vagal sensory nerves in esophagus. Gastroenterology 2006;130(Suppl 2):A252.
41. Derogatis LR, Lazarus L. SCL-90-R. Brief symptom inventory, and matching clinical rating scales. In: Maruish ME, ed. The use of treatment planning and outcome assessment. Hillsdale, New Jeresy: Lawrence Erlbaum Associates, 1994;217-218.
42. Rao SSC, Hayek B, Summers RW. Impedance planimetry: an integrated approach for assessing sensory, active and passive biomechanical properties of the esophagus. Am J Gastroenterol 1995;90:431-8.
43. Burnstock G, Wood JN. Purinergic receptors: their role in nociception and primary afferent neurotransmission. Curr Opin Neurobiol 1996;6:526-32.
44. Rongen GA, Brooks SC, Pollard MJ, et al. Effect of adenosine on heart rate variability in humans. Clin Sci 1999;96:597-604.
45. Fredholm BB, Ijzerman AP, Jacobson KA, et al. International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 2001;53:352-527.
46. Burnstock G. Purine-mediated signalling in pain and visceral perception. Trends Pharmacol Sci 2001;22:182-8.
47. Christofi FL. Unlocking mysterie of gut sensory transmission: is adenosine the key? News Physiol Sci 2001;16:201-7.
48. Taiwo YO, Levine JD. Further confirmation of the role of adenyl cyclase and of cAMP-dependent protein kinase in primary afferent hyperalgesia. Neuroscience 1991;44:131-5.
49. Yu S, Undem BJ, Kollarik M. Vagal afferent nerves with nociceptive properties in guinea-pig esophagus. J Physiol 2005;563:831-42.
50. Wang ZJ, Neuhuber WL. Intraganglionic laminar endings in the rat esophagus contain purinergic P2X2 and P2X3 receptor immunoreactivity. Anat Embryol (Berl) 2003;207:363-71.
51. Jackson EK, Mi Z, Gillespie DG, et al. Metabolism of cAMP to adenosine in the renal vasculature. J Pharmacol Exp Ther 1997;283:177-82.
52. Boarder MR, Hourani SM. The regulation of vascular function by P2 receptors: multiple sites and multiple receptors. Trends Pharmacol Sci 1998;19:99-107.
53. Libert F, Van Sande J, Lefort A, et al. Cloning and functional characterization of a human A1 adenosine receptor. Biochem Biophys Res Commun 1992;187:919-26.
54. Ren H, Stiles GL. Characterization of the human A1 adenosine receptor gene. Evidence for alternative splicing. J Biol Chem 1994;269:3104-10.
55. Shim JO, Shin CY, Lee TS, et al. Signal transduction mechanism via adenosine A1 receptor in the cat esophageal smooth muscle cells. Cell Signal 2002;14:365-72.
56. Takeda T, Kassab G, Liu J, et al. Effect of atropine on the biomechanical properties of the oesophageal wall in humans. J Physiol 2003;547:621-8.
57. Takeda T, Nabae T, Kassab G, et al. Oesophageal wall stretch: the stimulus or distension induced oesophageal sensation. Neurogastroenterol Motil 2004;16:721-8.
58. Richter JE, Dalton CB, Bradley LA, et al. Oral nifedipine in the treatment of noncardiac chest pain in patients with nutcracker esophagus. Gastroenterology 1987;93:21-8.
59. Barlow JD, Gregersen H, Thompson DG. Identification of the biomechanical factors associated with the perception of distension in the human esophagus. Am J Physiol Gastrointest Liver Physiol 2002;282:G683- 9.
60. Eherer AJ, Schwetz I, Hammer HF, et al. Effect of sildenafil on oesophageal motor function in healthy subjects and patients with oesophageal motor disorders. Gut 2002;50:758-64.
61. Lee JI, Park H, Kim JH, et al. The effect of sildenafil on oesophageal motor function in healthy subjects and patients with nutcracker oesophagus. Neurogastroenterol Motil 2003;15:617-623.
62. Pickering M, Campion D, Jones FX. Reflex cardiorespiratory effects of nociceptive oesophageal distension in the decerebrate rat. Exp Physiol 2002;87:41-8.